logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Twenty years'experience of rubella vaccination in Sweden : 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination.

    Article - En anglais

    Two different strategies for the prevention of rubella-induced malformations have now been practised in Sweden, both reaching 90% or more of the target populations.

    The first was initiated in 1973-1974 and targeted schoolgirls, susceptible women after pregnancy and women at special risk.

    The second programme-a two-dose measles, mumps, rubella vaccination (MMR) of both boys and girls at the ages of 18 months and 12 years-was introduced in 1982.

    The percentage of susceptible pregnant women was gradually reduced from 12% in 1975 to 2.8% in 1987 and to just below 2%. in 1994.

    The majority of the non immune are unvaccinated, these being either Swedes born before 1963 or immigrants.

    Before 1974 on average 14 severely rubella damaged children were reported yearly.

    Between 1975 and 1985 only a mean of two cases per year were recorded.

    Since 1985 no child with the rubella syndrome has been registered.

    Mots-clés Pascal : Enfant, Homme, Femelle, Postpartum, Rubéole, Virose, Infection, Vaccination, Immunoprophylaxie, Programme sanitaire, Etude longitudinale, Epidémiologie, Prévalence, Pays Scandinaves, Europe, Suède

    Mots-clés Pascal anglais : Child, Human, Female, Puerperium, Rubella, Viral disease, Infection, Vaccination, Immunoprophylaxis, Sanitary program, Follow up study, Epidemiology, Prevalence, Scandinavia, Europe, Sweden

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0527073

    Code Inist : 002B05A02. Création : 13/02/1998.